Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Resorcinol is an organic compound, a phenol derivative, that has been utilized in dermatological applications for over a century. It functions as a keratolytic agent by promoting the loosening and shedding of the outer layer of the skin, which is beneficial for treating conditions such as acne, psoriasis, and seborrheic dermatitis. Additionally, Resorcinol exhibits antiseptic and antimicrobial properties by disrupting the cell walls of bacteria and fungi and denaturing their proteins and enzymes. It also possesses anti-inflammatory and antipruritic effects, partly by promoting the formation of prostaglandin E. Resorcinol is found in both over-the-counter and prescription topical treatments for various skin disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Resorcinol.